Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02387125
Title A Phase 1b Safety Study of CMB305 (Sequentially Administered LV305 and G305) in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Immune Design
Indications

myxoid liposarcoma

lung non-small cell carcinoma

melanoma

ovarian cancer

Advanced Solid Tumor

sarcoma

fallopian tube carcinoma

synovial sarcoma

Therapies

CMB305

Age Groups: adult
Covered Countries USA


No variant requirements are available.